An Epigenetic Marker Panel for Detection of Lung Cancer Using Cell-Free Serum DNA
- 1 July 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 17 (13), 4494-4503
- https://doi.org/10.1158/1078-0432.ccr-10-3436
Abstract
Purpose: We investigated the feasibility of detecting aberrant DNA methylation of some novel and known genes in the serum of lung cancer patients. Experimental Design: To determine the analytic sensitivity, we examined the tumor and the matched serum DNA for aberrant methylation of 15 gene promoters from 10 patients with primary lung tumors by using quantitative methylation-specific PCR. We then tested this 15-gene set to identify the more useful DNA methylation changes in the serum of a limited number of lung cancer patients and controls. In an independent set, we tested the six most promising genes (APC, CDH1, MGMT, DCC, RASSF1A, and AIM1) for further elucidation of the diagnostic application of this panel of markers. Results: Promoter hypermethylation of at least one of the genes studied was detected in all 10 lung primary tumors. In majority of cases, aberrant methylation in serum DNA was accompanied by methylation in the matched tumor samples. In the independent set, using a single gene that had 100% specificity (DCC), 35.5% (95% CI: 25–47) of the 76 lung cancer patients were correctly identified. For patients without methylated DCC, addition of a logistic regression score that was based on the five remaining genes improved sensitivity from 35.5% to 75% (95% CI: 64–84) but decreased the specificity from 100% to 73% (95% CI: 54–88). Conclusion: This approach needs to be evaluated in a larger test set to determine the role of this gene set in early detection and surveillance of lung cancer. Clin Cancer Res; 17(13); 4494–503. ©2011 AACR.Keywords
Other Versions
This publication has 53 references indexed in Scilit:
- Molecular Analysis of Plasma DNA for the Early Detection of Lung Cancer by Quantitative Methylation-Specific PCRClinical Cancer Research, 2010
- Detection of Aberrant Methylation of Four Genes in Plasma DNA for the Detection of Breast CancerJournal of Clinical Oncology, 2006
- Quantitation of Promoter Methylation of Multiple Genes in Urine DNA and Bladder Cancer DetectionJNCI Journal of the National Cancer Institute, 2006
- Promoter Hypermethylation of Multiple Genes in Sputum Precedes Lung Cancer Incidence in a High-Risk CohortCancer Research, 2006
- Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: A nested case-control studyInternational Journal of Cancer, 2005
- Lung Cancer ScreeningThe New England Journal of Medicine, 2005
- Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung CancerClinical Cancer Research, 2004
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- Aberrant DNA Methylation in Lung Cancer: Biological and Clinical ImplicationsThe Oncologist, 2002
- IntroductionAnnals of the New York Academy of Sciences, 2001